<code id='263A16A432'></code><style id='263A16A432'></style>
    • <acronym id='263A16A432'></acronym>
      <center id='263A16A432'><center id='263A16A432'><tfoot id='263A16A432'></tfoot></center><abbr id='263A16A432'><dir id='263A16A432'><tfoot id='263A16A432'></tfoot><noframes id='263A16A432'>

    • <optgroup id='263A16A432'><strike id='263A16A432'><sup id='263A16A432'></sup></strike><code id='263A16A432'></code></optgroup>
        1. <b id='263A16A432'><label id='263A16A432'><select id='263A16A432'><dt id='263A16A432'><span id='263A16A432'></span></dt></select></label></b><u id='263A16A432'></u>
          <i id='263A16A432'><strike id='263A16A432'><tt id='263A16A432'><pre id='263A16A432'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:98179
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Readout Newsletter: XBI biotech index, Akero Therapeutics
          Readout Newsletter: XBI biotech index, Akero Therapeutics

          Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Colorectal cancer study finds potential in overlooked immune cell

          Stainingrevealsdifferentimmunecellsinahealthyhumancolon.CourtesyOliviaNewton-JohnCancerResearchinsti